The study of GABA, SCN1A, SCN2A gene polymorphism in epilepsy patients with a history of febrile seizures

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044081

Enrollment

Unknown

Registered

2021-03-09

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

grouped according to the history of febrile convulsion:Nil

Eligibility

Sex/Gender

All

Age

3 Years to 87 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of epilepsy; 2. with or without a history of febrile convulsions; 3. According to the clinical manifestations and EEG can be accurately classified (focal, comprehensive).

Exclusion criteria

Exclusion criteria: Excludes any of the following situations: 1. People with central nervous system progressive encephalopathy or progressive structural damage; 2. There are significant heart, liver, renal insufficiency and other medical diseases; 3. Significant mental retardation; 4. Have a history of alcohol and drug abuse;

Design outcomes

Primary

Measure	Time frame
GABA;SCN1A;SCN2A;	—

Countries

China

Contacts

Public ContactSun Yanping

The Affiliated Hospital of Qingdao University

ruthysyp@163.com+86 17853291196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026